GlassScriptPhysician profile
Khushvant S Bhola
NPI 1265438220
$13,005.87
in general payments reported to CMS, 2019-2025
37 companies · $2,474 in 2025
The $2,474 reported for 2025 was more than what 86% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $941 · 2020: $751 · 2021: $1,141 · 2022: $3,776 · 2023: $1,193 · 2024: $2,730 · 2025: $2,474.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,366 · Education: $31.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,366.01 |
| Education | $31.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,117.78 | 2019-2025 | Eterna, Proclaim, Mitraclip |
| Boston Scientific Corporation | $3,270.12 | 2020-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Medtronic, INC. | $806.05 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Interstim |
| Genesys Orthopedics Systems, L.L.C. | $638.98 | 2021 | |
| Abbvie INC. | $572.32 | 2021-2025 | Qulipta, Botox, Ubrelvy |
| Aurora Spine, INC. | $568.66 | 2022 | |
| Collegium Pharmaceutical, INC. | $482.56 | 2020-2025 | Xtampza, Belbuca |
| Amgen INC. | $174.26 | 2019-2023 | |
| Biotronik Nro, INC. | $154.08 | 2024-2025 | Prospera |
| Lundbeck LLC | $135.73 | 2024-2025 | Vyepti |
| Novartis Pharmaceuticals Corporation | $123.22 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $120.42 | 2019-2023 | Ztlido |
| Saluda Medical Americas, INC. | $112.68 | 2025 | Evoke |
| Nevro Corp. | $101.50 | 2019-2024 | Senza |
| Curonix LLC | $71.40 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $67.83 | 2023-2025 | Relistor |
| Tersera Therapeutics LLC | $65.34 | 2024 | Prialt |
| Lilly USA, LLC | $45.59 | 2019-2021 | |
| Merz Pharmaceuticals, LLC | $43.31 | 2025 | Xeomin |
| Microtransponder, INC. | $38.20 | 2024 | |
| Grt US Holding, INC. | $31.23 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $25.75 | 2025 | Ajovy |
| Mml US, INC. | $24.00 | 2025 | Reactiv8 |
| Biohaven Pharmaceuticals, INC. | $19.42 | 2021 | |
| Electronic Waveform Lab, INC. | $19.03 | 2025 | |
| Medtronic USA, INC. | $18.02 | 2020 | |
| Pacira Therapeutics, INC. | $17.57 | 2019 | |
| Averitas Pharma INC. | $17.56 | 2023 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $16.89 | 2025 | |
| Pfizer INC. | $16.00 | 2023 | |
| International Rehabilitative Sciences, INC | $15.35 | 2024 | Rs 4i Plus Sequential Stimulator |
| Tonix Medicines, INC. | $13.91 | 2025 | Tonmya |
| Daiichi Sankyo INC. | $13.55 | 2019 | |
| Vanda Pharmaceuticals INC. | $12.75 | 2019 | |
| Stimwave Technologies Incorporated | $11.93 | 2019 | |
| Janssen Biotech, INC. | $11.55 | 2021 | |
| Stryker Corporation | $11.33 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khushvant Bhola listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.